 differences were
found for other outcomes such as DVT, recurrent varicosity, recurrent ulceration, edema, lumps, pigmentation,
or recurrent ulceration. Outcomes are presented in
Supplementary Table VI (online only).
Adverse events.
Minor AEs. EVLA was signiÔ¨Åcantly associated with
increased risk of minor AEs than CAC (RR, 3.29; 95% CI,
2.32-4.